|
Pfizer hiked its full-year profit guidance, citing its strong business performance and cost cuts, even as sales for the period fell.
|
|
The flavor-and-fragrance company said full-year net profit for 2024 rose 22% to $1.2 billion, beating analyst expectations.
|
|